BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 21455597)

  • 1. Matrix metalloproteinase-9 is associated with relapse and prognosis of patients with colorectal cancer.
    Chu D; Zhao Z; Zhou Y; Li Y; Li J; Zheng J; Zhao Q; Wang W
    Ann Surg Oncol; 2012 Jan; 19(1):318-25. PubMed ID: 21455597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RhoE is associated with relapse and prognosis of patients with colorectal cancer.
    Zhou J; Yang J; Li K; Mo P; Feng B; Wang X; Nie Y; Fan D
    Ann Surg Oncol; 2013 Jan; 20(1):175-82. PubMed ID: 22941156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of high-risk stage II and stage III colorectal cancer by analysis of MMP-21 expression.
    Wu T; Li Y; Liu X; Lu J; He X; Wang Q; Li J; Du X
    J Surg Oncol; 2011 Dec; 104(7):787-91. PubMed ID: 21656525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
    Horiuchi S; Yamamoto H; Min Y; Adachi Y; Itoh F; Imai K
    J Pathol; 2003 Aug; 200(5):568-76. PubMed ID: 12898592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase-9 is associated with disease-free survival and overall survival in patients with gastric cancer.
    Chu D; Zhang Z; Li Y; Zheng J; Dong G; Wang W; Ji G
    Int J Cancer; 2011 Aug; 129(4):887-95. PubMed ID: 20957628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum matrix-metalloproteinase-1 is a bona fide prognostic marker for colorectal cancer.
    Tahara K; Mimori K; Iinuma H; Iwatsuki M; Yokobori T; Ishii H; Anai H; Kitano S; Mori M
    Ann Surg Oncol; 2010 Dec; 17(12):3362-9. PubMed ID: 20617463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
    Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K
    Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase-9 activity is associated with poor prognosis in T3-T4 node-negative colorectal cancer.
    Cho YB; Lee WY; Song SY; Shin HJ; Yun SH; Chun HK
    Hum Pathol; 2007 Nov; 38(11):1603-10. PubMed ID: 17669467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer.
    Takeuchi T; Hisanaga M; Nagao M; Ikeda N; Fujii H; Koyama F; Mukogawa T; Matsumoto H; Kondo S; Takahashi C; Noda M; Nakajima Y
    Clin Cancer Res; 2004 Aug; 10(16):5572-9. PubMed ID: 15328199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High level of Notch1 protein is associated with poor overall survival in colorectal cancer.
    Chu D; Li Y; Wang W; Zhao Q; Li J; Lu Y; Li M; Dong G; Zhang H; Xie H; Ji G
    Ann Surg Oncol; 2010 May; 17(5):1337-42. PubMed ID: 20058190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gelatinases A and B expression in human colorectal cancer in upper Egypt: a clinicopathological study.
    Omran OM; Thabet M
    Ultrastruct Pathol; 2012 Apr; 36(2):108-16. PubMed ID: 22471433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of matrix metalloproteinase 7, laminin and type IV collagen-associated liver metastasis in human colorectal cancer: immunohistochemical approach.
    Ogawa M; Ikeuchi K; Watanabe M; Etoh K; Kobayashi T; Takao Y; Anazawa S; Yamazaki Y
    Hepatogastroenterology; 2005; 52(63):875-80. PubMed ID: 15966224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lymph node micrometastases and expression of metastasis-related gene proteins in patients with colorectal cancer].
    Fan YZ; Li XP; Liu WF; Li GM
    Zhonghua Wai Ke Za Zhi; 2006 Feb; 44(3):181-5. PubMed ID: 16635348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of Notch1, Jagged1, NF-κB and MMP-9 in colorectal cancer patients and the relationship to clinicopathological parameters.
    Zheng CG; Chen R; Xie JB; Liu CB; Jin Z; Jin C
    Cancer Biomark; 2015; 15(6):889-97. PubMed ID: 26406415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of matrix metalloproteinase-21 is associated with poor overall survival of patients with colorectal cancer.
    Huang Y; Li W; Chu D; Zheng J; Ji G; Li M; Zhang H; Wang W; Du J; Li J
    J Gastrointest Surg; 2011 Jul; 15(7):1188-94. PubMed ID: 21590459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic potential in T1 and T2 colorectal cancer.
    Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
    Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy.
    Unsal D; Akyurek N; Uner A; Erpolat OP; Han U; Akmansu M; Mentes BB; Dursun A
    Am J Clin Oncol; 2008 Feb; 31(1):55-63. PubMed ID: 18376229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological significance of the gene expression of matrix metalloproteinases and reversion-inducing cysteine-rich protein with Kazal motifs in patients with colorectal cancer: MMP-2 gene expression is a useful predictor of liver metastasis from colorectal cancer.
    Oshima T; Kunisaki C; Yoshihara K; Yamada R; Yamamoto N; Sato T; Makino H; Yamagishi S; Nagano Y; Fujii S; Shiozawa M; Akaike M; Wada N; Rino Y; Masuda M; Tanaka K; Imada T
    Oncol Rep; 2008 May; 19(5):1285-91. PubMed ID: 18425389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer.
    Yamamoto H; Iku S; Adachi Y; Imsumran A; Taniguchi H; Nosho K; Min Y; Horiuchi S; Yoshida M; Itoh F; Imai K
    J Pathol; 2003 Feb; 199(2):176-84. PubMed ID: 12533830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients.
    Scorilas A; Karameris A; Arnogiannaki N; Ardavanis A; Bassilopoulos P; Trangas T; Talieri M
    Br J Cancer; 2001 Jun; 84(11):1488-96. PubMed ID: 11384099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.